SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.80
Ask:
77.20
Spread: 1.40 (1.847%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Board Changes

1 Mar 2010 07:00

RNS Number : 7823H
Accsys Technologies PLC
01 March 2010
 



Regulatory Announcement

 

 

Company

Accsys Technologies PLC

TIDM

AXS

Headline

Released

1 March 2010

Number

 

 

AIM: AXS

NYSE Euronext Amsterdam: AXS

1 March 2010

 

ACCSYS TECHNOLOGIES PLC("Accsys" or " the Company")

 

Board Changes

 

Accsys announces the appointment of Hans Pauli to the board as Chief Financial Officer ("CFO"), with effect from 01 April 2010.

Mr Pauli replaces Kevin Wood who will become a non-executive director in which capacity he will be working with Mr Pauli to ensure a smooth transition.

In addition, Tim Paterson-Brown and Tom Priday are resigning as non-executive directors with effect from 31st March 2010 to concentrate on other business interests.

Hans Pauli, aged 50, will split his time between the London head office and The Netherlands at the Company's Arnhem production and development plant, affording the Company for the first time a board level presence in both London and Arnhem.

Hans brings with him a wealth of financial, investment, distribution and licensing experience, obtained in both public and private companies in a raft of sectors including bio-tech and banking. Hans was formerly Finance Director for OctoPlus N.V., a bio-tech company based in Holland and listed on Euronext Amsterdam.

Willy Paterson-Brown, the Company's Chairman commented:

"We warmly welcome Hans to the Company and believe that his experience coupled with his executive presence in Arnhem will strengthen the Company as Accoya® wood production in Arnhem continues to increase and as we see renewed global interest from potential licensees.

I would like to thank Kevin Wood, Tim Paterson-Brown and Tom Priday for their huge contributions to the Company. Kevin has been a valuable asset whilst CFO and we are very fortunate to retain his input as a non-executive director as Hans settles into his new role."

Further information on Hans Pauli

Johannes Catharina Hermanus Leonardus (Hans) Pauli is a director and sole owner of Dordtwijck B.V. and is a director of BAC B.V. and MedSciences Capital II B.V. Within the last five years he has also been director of PamGene B.V.

 

Within twelve months of his ceasing to be a director, RingRosa N.V went into liquidation in the second quarter of 2001.

 

There are no other disclosures to be made pursuant to paragraph (g) of Schedule Two of the AIM Rules in connection with Mr Pauli's appointment to the board of Accsys.

 

Ends

 

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

 

 +44 20 8150 8835

 

Matrix Corporate Capital LLP

 

Threadneedle 

Communications

 

Stephen Mischler

Anu Tayal

 

Graham Herring

Josh Royston

graham.herring@threadneedlepr.co.uk

josh.royston@threadneedlepr.co.uk

+44 20 3206 7000

 

 

+44 20 7653 9850

Citigate First Financial B.V.

Wouter van de Putte 

Menno Delken

 + 31 20 575 4080

 

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its 100% owned subsidiary, Titan Wood Limited (www.titanwood.com), which has manufacturing operations in Arnhem, the Netherlands, a European office in London and an Americas office in Dallas, Texas. Accsys' operations comprise three principal business units: (i) the Accoya® wood production facility located in Arnhem, The Netherlands; (ii) technology development, focused on a programme of continuous improvements to the process engineering and operating protocols for the acetylation of wood which are currently under development and the development of technology for the acetylation of wood fibre; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya™ wood elements across the globe.

Accoya® Wood (www.accoya.info) is produced by using a patented, non-toxic process that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood" via acetylation. Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most woods, its colour does not degrade when exposed to sunlight. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, increased coatings life, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. Leading applications include external doors and windows, shutters/shading, siding and cladding, decking, outdoor furniture/equipment and glulam beams for structural use. 

Tricoya® Wood Elements (www.tricoya.com) is Titan Wood's proprietary technology for the acetylation of wood fibres, chips, and particles for use in the fabrication of wood based composites, including panel products. These composites demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications which were once limited to solid wood or man-made products. Tricoya® Wood Elements is lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process, which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. The environmentally responsible process protects wood from rot by making it "inedible" to most micro-organisms and insects, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance. Acetylated wood's increased durability offers major carbon sequestration advantages, compared to other woods and man-made building materials such as steel, vinyl, and plastic.

Wood Composites include a range of derivative wood products which are manufactured by binding together the strands, particles, fibres, or veneers of wood together with adhesives to form composite materials. These products are engineered to precise design specifications which are tested to meet national or international standards.

 

ACCOYA®, TRICOYA® and the Trimarque Device are registered trademarks owned by Titan Wood Limited and may not be used or reproduced without written permission.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAKKADPPBKDNBB
Date   Source Headline
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSTotal Voting Rights
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.